Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 2, 1996, Pages 417-428

  Rasey, Janet S ^a   Koh, Wui Jin ^a   Evans, Margaret L ^a   Peterson, Lanell M ^a   Lewellen, Thomas K ^b   Graham, Michael M ^a,b   Krohn, Kenneth A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hypoxia; Imaging; Positron emission tomography; 18F fluoromisonidazole

Indexed keywords

FLUORINE 18; MISONIDAZOLE;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HYPOXIA; LUNG NON SMALL CELL CANCER; OXYGEN ELECTRODE; PATIENT POSITIONING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0030249455     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00325-2     Document Type: Article

References (47)

1. 1. Anderson, G. R.; Stoler, D. L.; Scarcello, L. A. Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype. J. Biol. Chem. 264(25):14885-14892; 1989.
2. 2. Brizel, D. M.; Rosner, G. L.; Harrelson, J.; Prosnitz, L. R.; Dewhirst, M. W. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 30(3):635-642; 1994.
3. 3. Casciari, J. J.; Graham, M. M.; Rasey, J. S. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Med. Phys. 22(7):1127-1139; 1995.
4. 4. Chapman, J. D. The detection and measurement of hypoxic cells in solid tumors. Cancer 54:2441-2449; 1984.
5. 3H-labelled misonidazole in the tumor-bearing mouse. Int. J. Radiat. Oncol. Biol. Phys. 18:347-351; 1989.
6. 6. Coleman, C. N. Hypoxia in tumors: A paradigm for the approach to biochemical and physiological heterogeneity. J. Natl. Cancer Inst. 80:310-317; 1988.
7. 7. Fenton, B. M.; Rofstad, E. K.; Degner, F. L.; Sutherland, R. M. Cryospectrophotometric determination of tumor intravascular oxyhemoglobin saturations: Dependence on vascular geometry and tumor growth. J. Natl. Cancer Inst. 80(20):1612-1619; 1988.
8. 8. Gatenby, R. A.; Coia, L. R.; Richter, M. P.; Katz, H.; Moldofsky, P. J.; Engstrom, P.; Brown, D. Q.; Brookland, R.; Broder, G. J. Oxygen tension in human tumors: In vivo mapping using CT-guided probes. Radiology 156:211-214; 1985.
9. 9. Gatenby, R. A.; Kessler, H. B.; Rosenblum, J. S.; Coia, L. R.; Moldofsky, P. J.; Hartz, W. H.; Broder, G. J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14(5):831-838; 1988.
10. 10. Graeber, T. G.; Osmanian, C.; Jacks, T.; Housman, D. E.; Kochs, C. J.; Lowe, S. W.; Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91; 1996.
11. 11. Graham, M. M. and Lewellen, B. L. High speed automated discrete blood sampling for positron emission tomography. J. Nucl. Med. 34(1):357-1360; 1993.
12. 12. Grierson, J. R.; Link, J. M.; Mathis, C. A.; Rasey, J. S.; Krohn, K. A. A radiosynthesis of fluorine-18 fluoromisonidazole. J. Nucl. Med. 30:343-350; 1989.
13. 13. Groshar, D.; McEwan, A. J. B.; Parliament, M. B.; Urtasun, R. C.; Golberg, L. E.; Hoskinson, M.; Mercer, J. R.; Mannan, R. H.; Wiebe, L. I.; Chapman, J. D. Imaging tumor hypoxia and tumor perfusion. J. Nucl. Med. 34(6):885-888; 1993.
14. 14. Hill, R. P. Tumor progression: Potential role of unstable genomic changes. Cancer Metastasis Rev. 9(2): 137-147; 1990.
15. 15. Hlatky, L.; Tsionou, C.; Hahnfeldt, P.; Coleman, C. N. Mammary fibroblasts may influence breast tumor angiogenesis, via hypoxia-induced vascular endothelial growth factor upregulation and protein expression. Cancer Res. 54(23):6083-6086; 1994.
16. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26:45-50; 1993.
17. 2 tension measurements. Cancer Res. 51:6098-6102; 1991.
18. 18. Höckel, M.; Vorndran, B.; Schlenger, K.; Baußmann, E.; Knapstein, P. G. Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol. 51:141-149; 1993.
19. 2-histography. Int. J. Radiat. Oncol. Biol. Phys. 19:953-961; 1990.
20. 20. Kalra, R.; Jones, A.-M.; Kirk, J.; Adams, G. E.; Stratford, I. J. The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro. Int. J. Cancer 54:650-655; 1993.
21. 21. Koh, W.-J.; Bergman, K. S.; Rasey, J. S.; Peterson, L. M.; Evans, M. L.; Graham, M. M.; Grierson, J. R.; Lewellen, T. K.; Krohn, K. A.; Griffin, T. W. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int. J. Radiat. Oncol. Biol. Phys. 33(2):391-398; 1995.
22. 22. Koh, W.-J.; Rasey, J. S.; Evans, M. L.; Grierson, J. R.; Lewellen, T. K.; Graham, M. M.; Krohn, K. A.; Griffin, T. W. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 22:1-13; 1992.
23. 23. Kolstad, P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand. J. Clin. Lab. Invest. Suppl. 106:145-157; 1968.
24. 24. Lartigau, E.; Le Ridant, A.-M.; Lambin, P.; Weeger, P.; Martin, L.; Sigal, R.; Lusinchi, A.; Luboinski, B.; Eschwege, F.; Guichard, M. Oxygenation of head and neck tumors. Cancer 71(7):2319-2325; 1993.
25. 25. Lewellen, T. K.; Bice, A. N.; Harrison, R. L.; Pencke, M. D.; Link, J. M. Performance measurements of the SP-3000/UW time of flight emission tomograph. IEEE Trans. Nucl. Sci. 35(1):665-667; 1988.
26. 26. Lewellen, T. K.; Miyaoka, R. S.; Kohlmyer, S. G. Improving the performance of the SP-3000 PET detector modules. IEEE Trans. Nucl. Sci. 39(1):364-1368; 1992.
27. 27. Luk, C. K.; Veinot-Drebot, L.; Tjan, E.; Tannock, I. F. Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J. Natl. Cancer Inst. 82:684-692; 1990.
28. 28. Mannan, R. H.; Somayaji, V. V.; Lee, J.; Mercer, J. R.; Chapman, D.; Wiebe, L. I. Radioiodinated 1-(5-Iodo-5-deoxy-β-D-arabinofuranosyl)-2-nitroimidazole (Iodoazomycin Arabinoside: IAZA): A novel marker of tissue hypoxia. J. Nucl. Med. 32(9): 1764-1770; 1991.
29. 29. Moulder, J. E.; Rockwell, S. Tumor hypoxia: Its impact on cancer therapy. Cancer Metastasis Rev. 5:313-341; 1987.
30. 30. Olive, P. L.; Durand, R. E. Detection of hypoxic cells in a marine tumor with the use of the comet assay. J. Natl. Cancer Inst. 84:707-711; 1992.
31. 31. Parliament, M. B.; Chapman, J. D.; Urtasun, R. C.; McEwan, A. J.; Golberg, L.; Mercer, J. R.; Mannan, R. H.; Wiebe, L. I. Noninvasive assessment of human tumour hypoxia with 123 I-iodoazomycin arabinoside: Preliminary report of a clinical study. Br. J. Cancer 65:90-95; 1992.
32. 32. Raleigh, J. A.; Koch, C. J. The importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol. 40:2457-2464; 1990.
33. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29(3):427-431; 1994.
34. 34. Rasey, J. S.; Grunbaum, Z.; Magee, S.; Nelson, N. J.; Olive, P. L.; Durand, R. E.; Krohn, K. A. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat. Res. 111:292-304; 1987.
35. 35. Rasey, J. S.; Koh, W.-J.; Grierson, J. R.; Grunbaum, Z.; Krohn, K. A. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 17:985-991; 1989.
36. 36. Rasey, J. S.; Nelson, N. J.; Chin, L.; Evans, M. L.; Grunbaum, Z. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat. Res. 122:301-308; 1990.
37. 37. Rice, G. C.; Hoy, C.; Schimke, R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 83:5978-5982; 1986.
38. 38. Rice, G. C.; Ling, V.; Schimke, R. T. Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. Proc. Natl. Acad. Sci. USA 84:9261-9264; 1987.
39. 39. Rockwell, S. Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro. Int. J. Cancer 38:229-235; 1986.
40. 40. Rockwell, S.; Keyes, S. R.; Sartorelli, A. C. Preclinical studies of porfiromycin as an adjunct to radiotherapy. Radial. Res. 116:100-113; 1988.
41. 41. Sakata, K.; Kwok, T. T.; Murphy, B. J.; Laderoute, K. R.; Gordon, G. R.; Sutherland, R. M. Hypoxia-induced drug resistance: Comparison to P-glycoprotein-associated drug resistance. Br. J. Cancer 64:809-814; 1991.
42. 42. Teicher, B. A.; Lazo, J. S.; Sartorelli, A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res. 41(1):73-81; 1981.
43. 43. Valk, P. E.; Mathis, C. A.; Prados, M. D.; Gilbert, J. C.; Budinger, T. F. Hypoxia in human gliomas: Demonstration by PET with fluorine-18-fluoromisonidazole. J. Nucl. Med. 33(12):2133-2137; 1992.
44. 2 tension measurements in a murine fibrosarcoma. Radiat. Res. 120:477-493; 1989.
45. 2 tension measurements. Cancer Res. 51:3316-3322; 1991.
46. 46. Young, S. D.; Hill, R. P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: Analysis of transplanted murine tumors for evidence of DNA overreplication. Cancer Res. 50:5031-5038; 1990.
47. 47. Young, S. D.; Hill, R. P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: Anticancer drug sensitivity and metastatic potential. J. Natl. Cancer Inst. 82(5):371-380; 1990.